See other companies on Welcome to the Jungle

Q Bio

Clinical digital twin platform

Q Bio logo
21-100 employees
  • Healthcare
  • B2C
  • Internet of Things
  • SaaS
  • Wellbeing
San Carlos, CA

Company mission

To help create a world in which no lives are lost to treatable diseases, shaping healthier and safer future generations.

Top investors

7% employee growth in 12 months

Our take

The health tracking market has attracted significant interest from millions of Americans, yet current solutions lack depth and personalization. Many existing software and hardware options rely on manual data entry or offer limited functionality through wearables, failing to address the intricate data of individual bodies. This creates a demand for more innovative and comprehensive health monitoring tools.

Q Bio is addressing the gap by developing advanced healthcare hardware and software that tracks and analyzes individual bodily data to create a 'digital twin'. This concept provides users with a real-time representation of their health, enabling them to monitor changes over time and gain valuable insights to inform their healthcare decisions.

The company sets itself apart from other health-tracking services with its combined focus on granular detail and long-term monitoring. By visualizing data as 'digital twins', Q Bio makes complex health metrics more relatable and understandable, enhancing user engagement and empowering individuals to take control of their health in a meaningful way.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Company values

  • Grow together: The journey should be just as inspiring and important as the destination. We love to innovate and learn, and we strive to do better, and grow as a company, and as individuals, every day
  • Giant leaps; one step at a time: Tackling some of the hardest problems in biotech and healthcare simultaneously is not for the faint of heart! With such audacious goals, we keep the big picture in mind and stay nimble as we take on each new challenge
  • The team is greater than the sum of the parts: We are a multidisciplinary team from a variety of backgrounds, all with the determination to succeed together. We are accountable to each other, committed to collaboration, and seek to inspire one another
  • Tell us its impossible: At Q Bio, we believe assumptions are made to be broken. We are determined, persistent, and know that rapid iterations of trial and error are part of the game when you are building breakthrough tech

Funding (2 rounds)

Jul 2024

$27m

LATE VC

Mar 2020

$40m

SERIES B

Total funding: $67m

This company has top investors

Leadership

Dr. Garry Choy

(Co-Founder & Chief Medical Officer)

Alongside Q Bio, they have also worked at UnitedHealth Group since 2019, initially as a Senior Vice President and Deputy Chief Medical Officer, they now served as the Chief Clinical Transformation Officer. They are also the co-founder of andros where they have served as the Chief Medical Officer and Com0pliance Officer since 2013.